Update on disorders of sex development

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 1, 2012, Pages 28-32

  Houk, Christopher P ^a   Lee, Peter A ^b,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

46XY DSD; disorders of sex development; mutations in DSD

Indexed keywords

TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR SOX9;

ADRENAL HYPERPLASIA; CRYPTORCHISM; GENE MUTATION; GONAD DEVELOPMENT; GONADAL DYSGENESIS; HUMAN; HYPOSPADIAS; KARYOTYPING; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICOLEGAL ASPECT; MICROPENIS; NEPHROBLASTOMA; OUTCOME ASSESSMENT; PSYCHOLOGICAL WELL BEING; REVIEW; SERTOLI CELL; SERTOLI CELL ONLY SYNDROME; SEX DIFFERENTIATION DISORDER; SEXUAL DEVELOPMENT;

DECISION MAKING; DISORDERS OF SEX DEVELOPMENT; FEMALE; GENDER IDENTITY; GUIDELINES AS TOPIC; HUMANS; KARYOTYPING; MALE; PSYCHOSEXUAL DEVELOPMENT; QUALITY OF LIFE; SEX DETERMINATION ANALYSIS; SEXUAL DEVELOPMENT; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84655163885     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32834edacb     Document Type: Review

References (21)

1. Gorduza D, Vidal I, Birraux J, et al. The surgical challenges of disorders of sex development (DSD). Arch Esp Urol 2010; 63:495-504.
2. Douglas G, Axelrad ME, Brandt ML, et al. Consensus in guidelines for evaluation of DSD by the Texas Children's Hospital Multidisciplinary Gender Medicine Team. Int J Pediatr Endocrinol 2010; article ID 919707, 17 pp. doi: 10.1155/2010/919707.
3. Brain CE, Creighton SM, Mushtaqc KI, et al. Holistic management of DSD. Best Pract Res Clin Endocrinol Metab 2010; 24:335-354.
4. Mouriquand PD, Gorduza DB, Noché ME, Targnion A. Long-term outcome of hypospadias surgery: current dilemmas. Curr Opin Urol 2011 [Epub ahead of print].
5. Kleinemeier E, Jürgensen M, Lux A, et al., Disorders of Sex Development Network Working Group. Psychological adjustment and sexual development of adolescents with disorders of sex development. J Adolesc Health 2010; 47:463-471.
6. Houk CP, Lee PA. Approach to assigning gender in 46,XX congenital adrenal hyperplasia with male external genitalia: replacing dogmatism with pragmatism. J Clin Endocrinol Metab 2010; 95:4501-4508.
7. Ahmed SF, Achermann JC, Arlt W, et al. UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development. Clin Endocrinol 2011; 75:12-26. doi: 10.1111/j.1365-2265.2011. 04076.x.
8. Rodie M, McGowan R, Mayo A, et al. Factors that influence the decision to perform a karyotype in suspected disorders of sex development: lessons from the Scottish genital anomaly network register. Sex Dev 2011; 5:103-108; doi: 10.1159/000326815.
9. Austin J, Tamar-Mattis A, Mazur T, et al. Disorders of sex development - when and how to tell the patient. Pediatr Endocrinol Rev 2011; 8:213-217.
10. Cools M, Wolffenbuttel KP, Drop SL, et al. Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev 2011; 5:167-180.
11. Chalmers LJ, Doherty P, Migeon CJ, et al. Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Biol Sex Differences 2011; 2:5; http://www.bsd-journal.com/content/2/1/5.
12. White S, Ohnesorg T, Notini A, et al. Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis. PLoS One 2011; 6:e17793. doi: 10.1371/journal.pone.0017793.
13. Dai YL, Fu JF, Hong F, et al. WT1 mutation as a cause of 46 XY DSD and Wilm's tumor: a case report and literature review. Acta Paediatr 2011; 100:e39-e42; doi: 10.1111/j.1651-2227.2011.02167.x.
14. Köhler B, Biebermann H, Friedsam V, et al. Analysis of the Wilms' tumor suppressor gene (WT1) in patients 46,XY disorders of sex development. J Clin Endocrinol Metab 2011; 96:E1131-E1136.
15. Philibert P, Polak M, Colmenares A, et al. Predominant sertoli cell deficiency in a 46,XY disorders of sex development patient with a new NR5A1/SF-1 mutation transmitted by his unaffected father. Fertil Steril 2011; 95:1788.e5-1788.e9.
16. Warman DM, Costanzo M, Marino R, et al. Three new SF-1 (NR5A1) gene mutations in two unrelated families with multiple affected members: withinfamily variability in 46,XY subjects and low ovarian reserve in fertile 46,XX subjects. Horm Res Paediatr 2011; 75:70-77.
17. Fernández-Cancio M, Audí L, Andaluz P, et al. SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation. Int J Androl 2011. doi: 10.1111/j.1365-2605.2010.01136.x. [Epub ahead of print]
18. Berra M, Williams EL, Muroni B, et al. Recognition of 5a-reductase-2 deficiency in an adult female 46XY DSD clinic. Eur J Endocrinol 2011; 164:1019-1025.
19. Schwentner C, Czyz J, Seibold J, et al. Long-term biochemical evaluation of the androgen receptor pathway in males with disorders of sex development. World J Urol 2010 [Epub ahead of print].
20. Ferraz-de-Souza B, Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol Cell Endocrinol 2011; 336:198-205.
21. Gaspari L, Paris F, Philibert P, et al. 'Idiopathic' partial androgen insensitivity syndrome in 28 newborn and infant males: impact of prenatal exposure to environmental endocrine-disruptor chemicals? Eur J Endocrinol 2011 [Epub ahead of print].